Targeted sequencing involves sequencing a small region or set of regions of the genome, such as particular chromosomes, exomes, or individual genes of scientific or clinical interest.
This provides a highly cost effective alternative to whole genome sequencing, especially when only a small portion of the genome is required. Due to the smaller size of the regions targeted sequencing captures, deeper sequencing can be performed at a lower cost, ensuring rare and novel mutations are captured by the sequencing.
Targeted sequencing can be performed on a wide variety of species to observe specific intronic and exonic regions, this is especially useful when analysing mutations in model organisms such as C. elegans.
This technique is also a popular approach to sequence many individuals in order to discover, screen or validate genetic variation within a population.
Targeted sequencing is at the forefront of cancer research and treatment. By sequencing known genes of clinical relevance, mutations can be detected which may interfere with a particular treatment, allowing oncologists to select a more effective therapy.
A variety of options are available for targeted sequencing:
- Custom designed targeted enrichment
- Next generation sequencing panels
- Exome sequencing
- Amplicon sequencing
For further information and prices please contact us or call +44 (0)115 973 9012